Incidence, prevalence, and mortality of type 1 diabetes in children and youth in Burkina Faso 2013-2022.

Autor: Sagna Y; Service de Médecine Interne CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso; INSSA, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso. Electronic address: my_sagna@yahoo.fr., Bagbila WPAH; Service de Médecine Interne CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso; INSSA, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso., Sawadogo N; Service de Médecine Interne, CHUR de Ouahigouya, Burkina Faso; Faculté de Médecine, Université de Ouahigouya, Ouahigouya, Burkina Faso., Savadogo PPC; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso., Zoungrana L; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso; UFR/SDS, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso., Séré L; Service de Médecine Interne, CHU de Tengandogo, Ouagadougou, Burkina Faso., Yanogo ADR; Service de Médecine Interne, CHU de Tengandogo, Ouagadougou, Burkina Faso., Saloukou KEM; Service de Médecine, CHR de Koudougou, Médecine, Koudougou, Burkina Faso., Zemba D; Service de Médecine, CHR de Tenkodogo, Burkina Faso., Zio GU; Service de Médecine, CHR de Tenkodogo, Burkina Faso., Zombre YT; Service de Médecine, CHR de Fada N'Gourma, Burkina Faso., Millogo R; Service de Médecine, CHR de Fada N'Gourma, Burkina Faso., Traoré S; Service de Médecine, CHR de Ziniaré, Médecine, Ziniaré, Burkina Faso., Ilboudo A; Service de Médecine, CHR de Gaoua, Burkina Faso., Bognounou R; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso; UFR/SDS, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso., Ouedraogo NCJ; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso., Nikiema P; Service de Médecine, CHR de Koudougou, Médecine, Koudougou, Burkina Faso., Bengaly S; Service de Médecine Interne, CHU de Tengandogo, Ouagadougou, Burkina Faso., Gilberte Kyelem C; Service de Médecine Interne CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso; INSSA, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso., Guira O; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso; UFR/SDS, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso., Maniam J; Life for a Child Program, Diabetes NSW & ACT, Sydney, New South Wales, Australia., Ogle GD; Life for a Child Program, Diabetes NSW & ACT, Sydney, New South Wales, Australia., Ouedraogo MS; Service de Médecine Interne CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso; INSSA, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso., Drabo JY; Service de Médecine Interne, CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso; UFR/SDS, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso.
Jazyk: angličtina
Zdroj: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Jan; Vol. 207, pp. 111086. Date of Electronic Publication: 2024 Jan 03.
DOI: 10.1016/j.diabres.2023.111086
Abstrakt: Aim: There are no data on type 1 diabetes (T1D) incidence and prevalence in Burkina Faso. We aimed to determine these in persons aged <25 years (y) since the implementation of Life for a Child (LFAC) program in 2013.
Patients and Methods: Data were collected from the prospective program register. Diagnosis of T1D was clinical, based on presentation, abrupt onset of symptomatic hyperglycemia, need for insulin replacement therapy from diagnosis, and no suggestion of other diabetes types.
Results: We diagnosed 312 cases of T1D <25y in 2013-2022. Male-to-female ratio was 1:1. T1D incidence <25y per 100,000 population/year increased from 0.08 (CI 95% 0.07-0.60) in 2013 to 0.34 (CI 95% 0.26-0.45) in 2022 (p=0.002). Incidence <15y/y rose from 0.04 (CI 95% 0.01-0.10) to 0.27 (CI 95% 0.18-0.38) per 100,000/year in 2013 and 2022, respectively (p < 0.002). Prevalence per 100,000 population <25y was 0.27 (CI 95% 0.19-0.37) in 2013 and rose to 1.76 (CI 95% 1.546-1.99) in 2022 (p<0.0001). Mortality rate was 20 (CI 95% 13-29.6) per 1,000-person y.
Conclusions: There is a low but sharply rising T1D incidence and prevalence rates in children and youth in Burkina Faso since LFAC program implementation. It is very likely this is partly due to improved case detection. Mortality remains substantial.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: